Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flinn

Showing results (801-810 of 1,038) with videos related to

Pageof 104
Sort By:
Pediatrics|January 30, 2013
Management of newly diagnosed type 2 Diabetes Mellitus (T2DM) in children and adolescentsKenneth C Copeland, Janet Silverstein, Kelly R Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2004
Azacitidine induces demethylation of the Epstein-Barr virus genome in tumorsAnthony T C Chan, Qian Tao, Keith D Robertson, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2009
Regulation of Class IA PI 3-kinases: C2 domain-iSH2 domain contacts inhibit p85/p110alpha and are disrupted in oncogenic p85 mutantsHaiyan Wu, S Chandra Shekar, Rory J Flinn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Phase 1 study of lumiliximab with detailed pharmacokinetic and pharmacodynamic measurements in patients with relapsed or refractory chronic lymphocytic leukemiaJohn C Byrd, Susan O'Brien, Ian W Flinn, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|September 28, 2024
Gender Affirming Care Is Evidence Based for Transgender and Gender-Diverse YouthStephanie L Budge, Roberto L Abreu, Ryan E Flinn, et al.
The Lancet. Haematology|December 22, 2015
Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised studyChan Yoon Cheah, David Belada, Michelle A Fanale, et al.
Journal of Proteome Research|July 7, 2025
Mitochondria-Derived Reactive Oxygen Species Regulation of Tardigrade Osmobiosis Revealed by Proteomics of <i>Hypsibius exemplaris</i>Evan R Stair, Brendin B Flinn, Aaron C Grimmett, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2026
Glymphatic function restored by <i>α</i> 1-noradrenergic antagonism alleviates headache allodynia in miceAdriana Della Pietra, Adisa Kuburas, Mathew Sevao, et al.
Blood|March 11, 2015
The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemiaJennifer R Brown, Jacqueline C Barrientos, Paul M Barr, et al.
Leukemia & Lymphoma|December 10, 2020
Outcomes of patients with up to 6 years of follow-up from a phase 2 study of idelalisib for relapsed indolent lymphomasNina D Wagner-Johnston, Stephen J Schuster, Sven deVos, et al.
Pageof 104

Showing results (801-810 of 1,038) with videos related to

Sort By:
Pageof 104
Pediatrics|January 30, 2013
Management of newly diagnosed type 2 Diabetes Mellitus (T2DM) in children and adolescentsKenneth C Copeland, Janet Silverstein, Kelly R Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2004
Azacitidine induces demethylation of the Epstein-Barr virus genome in tumorsAnthony T C Chan, Qian Tao, Keith D Robertson, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2009
Regulation of Class IA PI 3-kinases: C2 domain-iSH2 domain contacts inhibit p85/p110alpha and are disrupted in oncogenic p85 mutantsHaiyan Wu, S Chandra Shekar, Rory J Flinn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Phase 1 study of lumiliximab with detailed pharmacokinetic and pharmacodynamic measurements in patients with relapsed or refractory chronic lymphocytic leukemiaJohn C Byrd, Susan O'Brien, Ian W Flinn, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|September 28, 2024
Gender Affirming Care Is Evidence Based for Transgender and Gender-Diverse YouthStephanie L Budge, Roberto L Abreu, Ryan E Flinn, et al.
The Lancet. Haematology|December 22, 2015
Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised studyChan Yoon Cheah, David Belada, Michelle A Fanale, et al.
Journal of Proteome Research|July 7, 2025
Mitochondria-Derived Reactive Oxygen Species Regulation of Tardigrade Osmobiosis Revealed by Proteomics of <i>Hypsibius exemplaris</i>Evan R Stair, Brendin B Flinn, Aaron C Grimmett, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2026
Glymphatic function restored by <i>α</i> 1-noradrenergic antagonism alleviates headache allodynia in miceAdriana Della Pietra, Adisa Kuburas, Mathew Sevao, et al.
Blood|March 11, 2015
The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemiaJennifer R Brown, Jacqueline C Barrientos, Paul M Barr, et al.
Leukemia & Lymphoma|December 10, 2020
Outcomes of patients with up to 6 years of follow-up from a phase 2 study of idelalisib for relapsed indolent lymphomasNina D Wagner-Johnston, Stephen J Schuster, Sven deVos, et al.
Pageof 104